Dyne Therapeutics Reports Positive Data from Phase 1/2 Studies
Dyne Therapeutics reports positive data from Phase 1/2 studies of muscle disease treatments, with encouraging results for myotonic dystrophy type 1 an...
Dyne Therapeutics reports positive data from Phase 1/2 studies of muscle disease treatments, with encouraging results for myotonic dystrophy type 1 an...
The Walt Disney Company partners with ValueAct Capital Management to consult on strategic matters and gain support for its slate of nominees. This col...
The stock market in Toronto dips on the first day of trading in the new year, with technology and financial shares underperforming. Energy and utiliti...
Pinstripes, an entertainment center operator, makes its debut in the public markets. Learn about their venues, SPAC deal, and the growing trend of fac...
Tesla's Model Y became the best-selling new car in Sweden, capturing 5.7% of all new car sales. A strike by Tesla mechanics has escalated into a large...
Learn about the closures and openings of offices, services, and markets on New Year's Day. Includes information on financial markets, delivery service...
The U.S. military's X-37B space plane launches on a covert mission, carrying undisclosed experiments and making no human occupants. The mission is exp...
2023 has been a phenomenal year for Nvidia as its stock soared, but questions remain about its future. Market technicians express unwavering optimism...
The Thailand SET Index has declined slightly, with certain companies experiencing drops while others emerge as leaders. Find out how the Asia-Pacific...
AI is set to revolutionize the workplace by unlocking internal knowledge and enhancing productivity through everyday conversational language.